Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

Novo Nordisk CEO Lars Jørgensen to step down amid increasing pressure from obesity drug competition and recent share price ...

For everything that was wrong about WeightWatchers, once upon a time it did something right. It tapped into the power of ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

A new study led by York University looking at the health data of nearly 15,000 people enrolled in a medically supervised weight-loss program found disparities among ethnic and sub-ethnic groups in how ...